Sector Chart NeuBase Therapeutics, Inc. Nasdaq

Equities

NBSE

US64132K2015

Delayed Nasdaq 02:00:00 11/05/2024 am IST 5-day change 1st Jan Change
0.378 USD -3.20% Intraday chart for NeuBase Therapeutics, Inc. -.--% -48.93%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
5.57TCr -
3.99TCr
3.96TCr
2.82TCr
2.63TCr